As to the conceptual classification of the mutated genes, mutation of was hardly ever overlapped with that of (Fig. phenotype and tumor cell proliferation. In B-lymphoma murine models, xenografted tumors bearing mutation offered lower H3K27 acetylation, higher M2 macrophage Flurizan recruitment, and more rapid tumor growth than those with wild-type control via FBXW7-NOTCH-CCL2/CSF1 axis. Our work thus contributed to the understanding of aberrant histone acetylation rules on tumor microenvironment as an alternative mechanism of tumor progression in DLBCL. mutants diminish H3K4 methylation, impede B-cell differentiation, and promote lymphoma development.8 is another key histone methyltransferase that inhibits gene transcription by affecting H3K27 methylation.9 Mutations in and modulating SWI/SNF chromatin redesigning complex and DNA methylation will also be frequent in hematological malignancies, including lymphoma.10,11 Moreover, and are two closely related KAT3 family members of histone acetyltransferases and function as transcriptional co-activators via H3K27 acetylation, as revealed by germinal center-directed deletion targeting or on murine models.12 Clinically, and mutations are frequently observed in DLBCL individuals, often mutually exclusive, and contribute to disease relapse and inferior prognosis.13 Based on the fact that epigenetic providers such as histone deacetylase inhibitors and hypomethylating providers have been growing as potential therapeutic approaches to counteract lymphoma growth and to overcome resistance to immunochemotherapy,14,15 mutation pattern of chromatin-modifying genes need to be fully identified in DLBCL, so as to translate knowledge of epigenetic aberrations into novel therapeutic targets. In addition to tumor cells themselves, alterations in the microenvironment play an essential part in tumor progression.16,17 Multiple mechanisms converge to tumor immunosuppressive status, including impaired functions of effector T and organic killer (NK) cells, as well as induction of myeloid-derived suppressor cells,18 and macrophage polarization toward M2 phenotype.19 Particularly, tumor-associated macrophage (TAM) acts as a key regulator in the creation of an immunosuppressive microenvironment that encourages tumor growth and metastasis.20,21 TAMs are derived from circulating monocytes and recruited to tumor sites by soluble tumor-derived chemotactic factors, mainly as CCL2 and CSF1.22,23 However, the mechanism of specific epigenetic alterations on TAM modulation remains unclear in DLBCL. In this study, we performed the genomic analysis in a large cohort of DLBCL individuals and showed that mutations were significantly associated with tumor progression. Meanwhile, underlying mechanisms of mutations on TAM polarization within the tumor microenvironment were analyzed both in vitro and in vivo. Results mutations contributed to tumor progression and the aberrant tumor microenvironment in DLBCL As demonstrated in Fig. ?Fig.1a,1a, mutations of chromatin-modifying genes were assessed in 619 individuals with newly diagnosed DLBCL (the training cohort ((Category I, Rabbit Polyclonal to SCAMP1 encoding methyltransferase, 121, 51, Flurizan and 18 instances), and (Category II, encoding Flurizan acetyltransferase, 52 and 42 instances), (Category III, encoding DNA methylation, 48 instances) and (Category IV, encoding chromatin remodeling, 54 instances). A total of 472 somatic mutations were recognized within 278 individuals, including 306 nonsynonymous somatic single-nucleotide variants (SNVs), 57 stopgain, 30 nonframeshift deletion or insertion, and 79 frameshift deletion or insertion (Fig. ?(Fig.1b).1b). and mutations primarily affected the practical FYRN, FYRC, and Collection website and undetermined website (residues between 1500 and 4500). and mutations primarily affected the HAT-KAT11 website. Many of the alterations were located at well-conserved amino acid positions across unique species, suggesting that these mutations may alter the protein function (Supplementary Fig. 1a). mutations were single-nucleotide substitutions, Flurizan with the common mutation (Y646 substitution) focusing on the conserved Collection website. and mutations were relatively disseminated (Supplementary Table 1). As to the conceptual classification of the mutated genes, mutation of was hardly ever overlapped with.
Category: Kinases, Other
One important example is the association of HIV, an enveloped RNA virus, with membrane domains [155, 156]
One important example is the association of HIV, an enveloped RNA virus, with membrane domains [155, 156]. membrane of eukaryotes but could potentially be a ubiquitous membrane-organizing principle in several other biological systems. is the most studied of these and has been used for sensing cholesterol [60]. In a recent study, PFO was modified to probe the transbilayer distribution of cholesterol on membrane bilayers [61]. Other proteins have been isolated from different organisms that bind either selectively or non-selectively to different lipids. Lysenin, a protein isolated from the earthworm (reviewed in [147]). Intoxification of host cells by VacA is initiated by binding of the toxin to the plasma membrane, followed by toxin oligomerization, membrane insertion, and pore formation [148]. Current models suggest that one or more of these events occur in lipid rafts. Early studies demonstrating VacA associates with lipid rafts relied on biochemical approaches to isolate raft-enriched fractions and/or depleting cells of cholesterol to interfere with raft integrity and function [5, 149C151]. More recent work has now confirmed VacAs raft association by showing it preferentially associates with the raft phase in Microcystin-LR GPMVs [152]. How VacA is targeted to lipid rafts is currently not entirely clear and may involve multiple mechanisms. Some studies indicate that sphingomyelin, one of the receptors of VacA, acts to recruit VacA to rafts [5], while Microcystin-LR others have shown that initial binding of VacA is to receptors in non-lipid raft microdomains and the raft partitioning of VacA occurs subsequently as a result of clustering [151]. Interestingly, unlike other bacterial toxins such as CTx that depend at least in part on multivalent binding to their receptor to facilitate raft targeting, VacA DLL4 need not form oligomers in order to partition into rafts [152] (Figure 3B). Furthermore, the ability of the toxin to form pores is not required for it to associate with rafts [152]. Why then does VacA associate with rafts? Microcystin-LR One potential answer is that this is linked to VacAs internalization mechanism: VacA enters cells via clathrin-independent endocytic pathways, which are typically raft-dependent [153]. However, how rafts influence VacAs pore-forming activity is not yet known. For example, it is currently unclear whether the structure of pores formed by VacA differs in raft versus non-raft environments. This is an especially important question because there are multiple examples of pore-forming toxins that associate with rafts [154]. Future studies using VacA should help to provide insights into this question, as well as to better delineate raft targeting mechanisms for this interesting class of toxins. HIV selectively binds and fuses at raft/non-raft boundaries Not just bacteria, but also viruses are known to target lipid rafts. One important example is the association of HIV, an enveloped RNA virus, with membrane domains [155, 156]. Rafts are thought to play a role in multiple steps in HIV assembly and release. For example, cholesterol is important for viral fusion and infection of cells by HIV [157]. Furthermore, the host cell receptor for HIV, receptor CD4, has been identified as a raft-associated protein [158]. However, until recently, the exact mechanisms by which the virus targets rafts for entry into cells has remained enigmatic. In a series of interesting studies from both a membrane biology and virology standpoint, HIV has been shown to selectively bind and fuse to the interface between liquid ordered (Lo) and liquid disordered (Ld) domains [159C161]. Initial evidence in support of this idea came from studies showing that reconstitution of the fusion peptide (FP) of HIV gp41 into liposomes mimicking the composition of HIV viral membranes facilitates their fusion to supported bilayers consisting of mixtures of Lo and Ld domains [160]. Strikingly, liposomes containing HIV FP preferentially accumulated at the boundary between Lo and Ld domains. Further, both phase separation and cholesterol were found to be required to facilitate fusion. This behavior was specific to the HIV FP because liposomes containing the influenza FP showed no preference for the boundary [160]. HIV-1 psuedoviruses also preferentially bound to the domain boundary, demonstrating this behavior is not limited to the isolated FP [160]. An interesting question raised by these findings is why HIV virions prefer to fuse at domain.